FDA Inspection 1275693 — Saint Luke's Hospital Of Kansas City
The FDA completed an inspection of Saint Luke's Hospital Of Kansas City on Jun 25, 2025 in Kansas City, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 25, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Kansas City, MO (United States)